Skip to main content

Media Category: Treatments

Interview: Switching MS medication

Written by ParadigMS Foundation on .

BIOGRAPHY Melinda Magyari Melinda Magyari is the director of The Danish Multiple Sclerosis Registry (link: www.dmsr.dk/) and a consultant neurologist at the Danish Multiple Sclerosis Center (COI). Her major research area is in multiple sclerosis and other inflammatory disorders of the central nervous system with a special interest in the changing epidemiology and gender differences. Using nationwide population-based data sources her research addresses questions on comorbidities, reproductive issues, risk factors and socioeconomic consequences in multiple sclerosis. She is involved...

Continue reading

On-demand webinar: EBV (Epstein-Barr Virus) 

Written by ParadigMS Foundation on .

BIOGRAPHY  Niels Hellings Niels Hellings is Director of the Biomedical research Institute (BIOMED) and Professor Immunology at the Faculty of Medicine and Life Sciences of Hasselt University (COI).He graduated as master in bioscience-engineering at the Catholic University of Leuven (1996) and consequently obtained a PhD in immunology at Hasselt University (2000). He was visiting postdoctoral scientist at McGill University (Montréal), before returning to Hasselt University to set up his own research group. Currently, Niels Hellings is director of the biomedical research institute...

Continue reading

On-demand webinar: Real-life data on switching medication 

Written by ParadigMS Foundation on .

BIOGRAPHY MELINDA MAGYARI Melinda Magyari is the director of The Danish Multiple Sclerosis Registry (link: www.dmsr.dk/) and a consultant neurologist at the Danish Multiple Sclerosis Center (COI). Her major research area is in multiple sclerosis and other inflammatory disorders of the central nervous system with a special interest in the changing epidemiology and gender differences. Using nationwide population-based data sources her research addresses questions on comorbidities, reproductive issues, risk factors and socioeconomic consequences in multiple sclerosis. She is involved...

Continue reading

Presentation – Risk in multiple sclerosis treatment

Written by ParadigMS Foundation on .

ABSTRACT Every MS patient is different, and prescribing the correct treatment based on MS disease characteristics and patientrelated factors (comorbidities, desire for children, etc) is no trivial matter. Anticipating potential complications associated with each disease-modifying therapy and taking the correct action before adverse events occur is a major challenge facing MS neurologists.In this first of a two-part ParadigMS series, Professors Maura Pugliatti and Carlo Pozzilli will share with you their strategies for identifying treatment risks based on individual patient characteristics....

Continue reading

Presentation – How to mitigate risk in treating multiple sclerosis

Written by ParadigMS Foundation on .

ABSTRACT No two MS patients are the same, and yet only a limited number of disease-modifying therapies are available for MS neurologists to treat their patients. In this second of a two-part series, Professors Maura Pugliatti and Carlo Pozzilli expand on their earlier presentation (Risk in Multiple Sclerosis Treatment) to guide you in how to manage and mitigate risks associated with treating MS patients. They follow a multifaceted approach based on their own experience and literature reports to provide a set of key messages underlying risk mitigation in MS treatment. MAURA PUGLIATTI Maura...

Continue reading

On-demand webinar – Cognition in MS: A Marker of Silent Progression?

Written by ParadigMS Foundation on .

10th November 2022, Pre-MENACTRIMS Symposium As a warm-up for the Seventh MENACTRIMS Congress, ParadigMS Foundation organised an enriching Pre-MENACTRIMS Symposium on Thursday November 10, 2022 in Cairo, Egypt. Here you can review the full keynote on Cognition in MS: A Marker of Silent Progression?. BIOGRAPHY CARLO POZZILLI Professor Pozzilli studied at the University of Rome “La Sapienza”. He then moved to the Hammersmith Hospital in London, UK, to take up a research post in 1980.In 1983, he became a Board Certified Neurologist at the University of Rome. In 1986 obtained a research...

Continue reading

Educational slide decks
endorsed by experts

Minimum two MS experts collaborate to produce an educational slide deck. These slide decks are presented (live) to ParadigMS members, peer reviewed and updated.
The slide decks are published on the ParadigMS website “on behalf of ParadigMS”.

Consensus publications

Based on the slide decks, publications are produced. These publications are peer reviewed and published as consensus publications.

Regional and national educational events

Regional (fe: Scandinavian countries, Benelux, …) or national events where state-of-the-art science is transferred to general neurologists and other care givers (nurses, etc) that are confronted with MS in their day to day practice.

Web-based educational tools and resources

Webinars can complement the educational events.

Medical education (ME) programs

The educational slide decks, events and webinars can be important building blocks of accredited educational programs.

FAQs

Do subscriptions auto-renew?
Your subscription will automatically renew on a monthly or yearly basis, depending on the plan you have chosen. If you cancel your plan, it will not renew at the end of your subscription cycle. It will end once the period you have paid for is over.
What happens if I subscribe as a healthcare practitioner if I am not a healthcare practitioner?
If you subscribe as a healthcare practitioner and it is proven that you are not a healthcare practitioner, you will be banned immediately from the community and could be liable to prosecution.
How can I cancel my trial or subscription?
You can cancel your trial or subscription in your account settings. If you cancel during the trial period you will not be charged.

Terms and Conditions

All the Terms and Conditions of the ParadigMS Foundation Website can be downloaded here.